Amryt Pharma PLC Sponsored ADR EBITDA Margin 2021-2022 | AMYT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Amryt Pharma PLC Sponsored ADR (AMYT) over the last 10 years. The current EBITDA margin for Amryt Pharma PLC Sponsored ADR as of September 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-09-30 | $0.24B | $0.02B | 9.84% |
| 2022-06-30 | $0.24B | $0.01B | 2.50% |
| 2022-03-31 | $0.23B | $0.01B | 4.70% |
| 2021-12-31 | $0.22B | $0.02B | 7.17% |
| 2021-09-30 | $0.21B | $0.02B | 9.48% |
| 2021-06-30 | $0.20B | $0.04B | 19.70% |
| 2021-03-31 | $0.19B | $0.03B | 16.67% |
| 2020-12-31 | $0.18B | $0.03B | 14.21% |
